Article

Children's and their parents' views on facing research risks for the benefit of others

Department of Clinical Bioethics, National Institutes of Health Clinical Center, Bldg 10, Room 1C118, Bethesda, MD 20892, USA.
JAMA Pediatrics (Impact Factor: 4.25). 02/2008; 162(1):9-14. DOI: 10.1001/archpediatrics.2007.3
Source: PubMed

ABSTRACT To assess children's and parents' attitudes regarding pediatric research that poses minimal risk or a minor increase over minimal risk and does not offer the potential to benefit the child clinically.
Separate in-person interviews with children and their parents.
Clinics where the children were receiving clinical care or participating in clinical research for asthma or cancer.
Children aged 7 to 14 years and their parents or legal guardians.
In-person interviews.
Respondents' willingness to enroll the child in nonbeneficial research and charitable activities that posed the same risks.
Overall, 81 child-parent pairs were interviewed. For a hypothetical study that would not benefit the child and posed a risk of headache, 71% of the children were willing to participate, and 72% of the parents would allow their children to participate. For a hypothetical study that would not benefit the child and posed a very small chance of a broken leg, 43% of the children and 24% of the parents endorsed the child's participation. Overall, respondents were equally willing to have the child help others by participating in nonbeneficial research or by participating in a charitable activity.
Most respondents were willing to have the child participate in some nonbeneficial research, and most did not consider nonbeneficial pediatric research to be more problematic than charitable activities for children. These findings provide empirical data to support the acceptability of exposing children to some research risks for the benefit of others.

Download full-text

Full-text

Available from: Tammara Jenkins, May 26, 2015
0 Followers
 · 
70 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: There are an increasing number of medical research studies involving children, including many long-term birth cohort studies. Involving children raises many issues, and little is known about children's own views. This study explored children's views (N = 5,851) on participation in a long-term screening study for type 1 diabetes. The results show that children 10 to 13 years of age have in general a positive attitude to pediatric research and emphasized trust in researchers. The children stressed the importance to receive information and to be involved in decisions. The children also reported feeling concerned about blood sampling and disease risk. Researchers involved in long-term pediatric research need to address these issues to promote involvement and decrease worry. © The Author(s) 2014.
    Journal of Empirical Research on Human Research Ethics 08/2014; 9(4). DOI:10.1177/1556264614544456 · 1.22 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Die Genehmigungsanträge für pädiatrische klinische Prüfungen müssen die hohen Anforderungen der gesetzlichen Vorgaben erfüllen. Über eine Umfrage unter vfa-Mitgliedsunternehmen (vfa: Verband Forschender Arzneimittelhersteller e. V.) wurden Rückmeldungen der Ethikkommissionen und der zuständigen Genehmigungsbehörden zu den Studienanträgen systematisch erfasst. Die meisten Einwände bezogen sich auf die Patienteninformation und Einwilligungserklärung, gefolgt von Einwänden zum Prüfplan. Nahezu 47% aller Einwände thematisierten spezielle pädiatrische Fragestellungen. Auf Basis der Analyse dieser Einwände wurden folgende Empfehlungen für die Antragssteller abgeleitet, um die Prozessqualität bei der Antragsstellung zu verbessern: Darstellung des maximal akzeptablen Risikos (Risikoschwelle), des Belastungsgrades und der Begriffe des minimalen Risikos und der minimalen Belastung; Berücksichtigung der pubertären Reife bei der Beschreibung von Kontrazeptionsmethoden; Erstellung von altersgerecht formulierten Zustimmungserklärungen, um die Einbeziehung minderjähriger Studienteilnehmer in den Entscheidungsprozess zu ermöglichen; Thematisierung der Einhaltung der Bestimmungen gemäß § 40 Abs. 4 AMG (Arzneimittelgesetz) sowie Bezug auf das genehmigte pädiatrische Prüfkonzept (PIP).
    Monatsschrift Kinderheilkunde 07/2012; 160(7). DOI:10.1007/s00112-011-2617-x · 0.28 Impact Factor
  • Source